Monopar Therapeutics MNPR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Monopar Therapeutics’s reported figures.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's invested capital?
- Monopar Therapeutics (MNPR) reported invested capital of $83.08M in Q1 2026.
- How has Monopar Therapeutics's invested capital changed year-over-year?
- Monopar Therapeutics's invested capital increased by 498.1% year-over-year, from $13.89M to $83.08M.
- What is the long-term trend for Monopar Therapeutics's invested capital?
- Over 2 years (2022 to 2025), Monopar Therapeutics's invested capital has grown at a 523.6% compound annual growth rate (CAGR), from $1.96M to $76.24M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).